CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
Pharmaceutical
COUR Pharmaceuticals Secures FDA Orphan Drug Designation for CNP-104 in Primary Biliary Cholangitis
CHICAGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed to induce...
Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations
Phase 2 single-arm, baseline-controlled trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of cutaneous venous malformations...
Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
– Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both...
Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors
SANTA CRUZ, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to...
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
GAITHERSBURG, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a leading public health company that delivers protective...
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
GAITHERSBURG, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the exercise of contract option...
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD)...
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/...
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO...
Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000
LONDON, UK / ACCESSWIRE / January 8, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has...
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today...
Laxxon Medical to Participate in 27th Annual Needham Growth Conference
NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Laxxon Medical, a leading pharma-technology company pioneering a new generation...
BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
Vancouver, British Columbia--(Newsfile Corp. - January 7, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or...
ClariMed Appoints Ross Dehmoobed as Vice President of Software and Launches Comprehensive Digital Health Services
CHADDS FORD, Pa., Jan. 7, 2025 /PRNewswire/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory...
MedPro Systems Announces DirectID – Salesforce.com on Salesforce AppExchange
MedPro Systems' customers can now benefit from real-time data integration, comprehensive compliance support and flexible data solutions. MOUNT ARLINGTON, N.J.,...
WCG Unveils 2025 Trends and Insights Report: Driving Innovation and Excellence in Clinical Research
PRINCETON, N.J., Jan. 7, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
InnoGI Technologies and Bac3Gel Forge Partnership to Revolutionize Gut Microbiome Research
DELFT, Netherlands, Jan. 7, 2025 /PRNewswire/ -- InnoGI Technologies and Bac3Gel are proud to announce a groundbreaking partnership that grants...
PharmaScroll Launches SocialBI: The Cutting-Edge Social Media Listening Tool for Real-Time Patient Insights
HYDERABAD, India, Jan. 7, 2025 /PRNewswire/ -- PharmaScroll, a renowned market research and business analytics organization is thrilled to announce...
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
The Keynote Address, entitled "Beyond Ketamine: Combined Interventional Treatment of Suicidal Depression and PTSD," will be presented at 10:30AM PT...